Therapeutic potential of Wenshen Xiaozheng Tang, a traditional chinese medicine prescription, for treating endometriosis

Reproductive Sciences

Volumn 20, Issue 10, 2013, Pages 1215-1223

  Zhang, Zhenzhen ^a,b   Hu, Chunping ^b   Tang, Weiwei ^a,b   Gui, Tao ^a,b   Qian, Ruyun ^a,b   Xing, Yuxia ^a,b   Cao, Peng ^b   Wan, Guiping ^a,b  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b Jiangsu Province Academy of Traditional Chinese Medicine   (China)

Author keywords

endometriosis; inflammation; invasion; Wenshen Xiaozheng Tang

Indexed keywords

CHINESE DRUG; CYCLOOXYGENASE 2; GELATINASE A; GELATINASE B; HERBACEOUS AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WENSHEN XIAOZHENG TANG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHINESE MEDICINE; COMMIPHORA; CONTROLLED STUDY; CORYDALIS; ENDOMETRIOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRUIT; LEGUME; NONHUMAN; PERITONEAL FLUID; PLANT ROOT; POLLEN; PRESCRIPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TYPHA ANGUSTIFOLIA;

ENDOMETRIOSIS; INFLAMMATION; INVASION; WENSHEN XIAOZHENG TANG;

ANIMALS; DRUGS, CHINESE HERBAL; ENDOMETRIOSIS; FEMALE; MEDICINE, CHINESE TRADITIONAL; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 84883729141     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719113483008     Document Type: Article

References (53)

1. Cosin R, Gilabert-Estelles J, Ramon LA, et al. Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis. Hum Reprod. 2010 ; 25 (2). 398-405
2. Giudice LC.. Clinical practice. Endometriosis. N Engl J Med. 2010 ; 362 (25). 2389-2398
3. Celik O, Hascalik S, Elter K, Tagluk ME, Gurates B, Aydin NE. Combating endometriosis by blocking proteasome and nuclear factor-kappaB pathways. Hum Reprod. 2008 ; 23 (11). 2458-2465
4. Augoulea A, Alexandrou A, Creatsa M, Vrachnis N, Lambrinoudaki I. Pathogenesis of endometriosis: the role of genetics, inflammation and oxidative stress. Arch Gynecol Obstet. 2012 ; 286 (1). 99-103
5. Pitsos M, Kanakas N. The role of matrix metalloproteinases in the pathogenesis of endometriosis. Reprod Sci. 2009 ; 16 (8). 717-726
6. Bruse C, Radu D, Bergqvist A. In situ localization of mRNA for the fibrinolytic factors uPA, PAI-1 and uPAR in endometriotic and endometrial tissue. Mol Hum Reprod. 2004 ; 10 (3). 159-166
7. Kyama CM, Debrock S, Mwenda JM, D'Hooghe TM. Potential involvement of the immune system in the development of endometriosis. Reprod Biol Endocrinol. 2003 ; 1: 123
8. Zhou WD, Yang HM, Wang Q, et al. SB203580, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis by down-regulating proinflammatory cytokines and proteolytic factors in a mouse model. Hum Reprod. 2010 ; 25 (12). 3110-3116
9. Chen Q, Zhou W, Pu D, Li Z, Huang Q, Chen Q. The inhibitory effect of 15-R-LXA4 on experimental endometriosis. Eur J Obstet Gynecol Reprod Biol. 2009 ; 145 (2). 200-204
10. Zheng Y, Liu X, Guo SW. Therapeutic potential of andrographolide for treating endometriosis. Hum Reprod. 2012 ; 27 (5). 1300-1313
11. Ozawa Y, Murakami T, Tamura M, Terada Y, Yaegashi N, Okamura K. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice. Fertil Steril. 2006 ; 86 (4 suppl 1). 1146-1151
12. Banu SK, Lee J, Speights VO, Starzinski-Powitz A, Arosh JA. Cyclooxygenase-2 regulates survival, migration, and invasion of human endometriotic cells through multiple mechanisms. Endocrinology. 2008 ; 149 (3). 1180-1189
13. Kyama CM, Mihalyi A, Simsa P, et al. Role of cytokines in the endometrial-peritoneal cross-talk and development of endometriosis. Front Biosci. 2009 ; 1: 444-454
14. Ueda M, Yamashita Y, Takehara M, et al. Gene expression of adhesion molecules and matrix metalloproteinases in endometriosis. Gynecol Endocrinol. 2002 ; 16 (5). 391-402
15. Collette T, Maheux R, Mailloux J, Akoum A. Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis. Hum Reprod. 2006 ; 21 (12). 3059-3067
16. Bruse C, Bergqvist A, Carlstrom K, Fianu-Jonasson A, Lecander I, Astedt B. Fibrinolytic factors in endometriotic tissue, endometrium, peritoneal fluid, and plasma from women with endometriosis and in endometrium and peritoneal fluid from healthy women. Fertil Steril. 1998 ; 70 (5). 821-826
17. Pino M, Galleguillos C, Torres M, et al. Association between MMP1 and MMP9 activities and ICAM1 cleavage induced by tumor necrosis factor in stromal cell cultures from eutopic endometria of women with endometriosis. Reproduction. 2009 ; 138 (5). 837-847
18. Domeij H, Modeer T, Quezada HC, Yucel-Lindberg T. Cell expression of MMP-1 and TIMP-1 in co-cultures of human gingival fibroblasts and monocytes: the involvement of ICAM-1. Biochem Biophys Res Commun. 2005 ; 338 (4). 1825-1833
19. Kennedy S, Bergqvist A, Chapron C, et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 2005 ; 20 (10). 2698-2704
20. Rocha AL, Reis FM, Petraglia F. New trends for the medical treatment of endometriosis. Expert Opin Investig Drugs. 2012 ; 21 (7). 905-919
21. Flower A, Liu JP, Chen S, Lewith G, Little P. Chinese herbal medicine for endometriosis. Cochrane Database Syst Rev. 2009 (3). CD006568
22. Li SP, Zhao J, Yang B. Strategies for quality control of Chinese medicines. J Pharm Biomed Anal. 2011 ; 55 (4). 802-809
23. Fan X, Cheng Y, Ye Z, Lin R, Qian Z. Multiple chromatographic fingerprinting and its application to the quality control of herbal medicines. Ana Chim Acta. 2006 ; 555 (12). 217-224
24. Guide for the Care and Use of Laboratory Animals. Washington, DC: National Research Council, National Academy Press ; 1996 :
25. Yavuz E, Oktem M, Esinler I, Toru SA, Zeyneloglu HB. Genistein causes regression of endometriotic implants in the rat model. Fertil Steril. 2007 ; 88 (4 suppl 1). 1129-1134
26. Szymanowski K, Chmaj-Wierzchowska K, Yantczenko A, et al. Endometriosis prophylaxis and treatment with the newly developed xenogenic immunomodulator RESAN in an animal model. Eur J Obstet Gynecol Reprod Biol. 2009 ; 142 (2). 145-148
27. Ji X, Gao J, Cai X, et al. Immunological regulation of Chinese herb Guizhi Fuling Capsule on rat endometriosis model. J Ethnopharmacol. 2011 ; 134 (3). 624-629
28. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008 ; 22 (3). 659-661
29. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001 ; 25 (4). 402-408
30. Xu H, Becker CM, Lui WT, et al. Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo. Fertil Steril. 2011 ; 96 (4). 1021-1028
31. Jiang HQ, Li YL, Zou J. Effect of recombinant human endostatin on endometriosis in mice. Chin Med J. 2007 ; 120 (14). 1241-1246
32. Wieser F, Cohen M, Gaeddert A, et al. Evolution of medical treatment for endometriosis: back to the roots?. Hum Reprod Update. 2007 ; 13 (5). 487-499
33. Scholl B, Bersinger NA, Kuhn A, Mueller MD. Correlation between symptoms of pain and peritoneal fluid inflammatory cytokine concentrations in endometriosis. Gynecol Endocrinol. 2009 ; 25 (11). 701-706
34. Wu MY, Ho HN. The role of cytokines in endometriosis. Am J Reprod Immunol. 2003 ; 49 (5). 285-296
35. Bedaiwy MA, Falcone T.. Peritoneal fluid environment in endometriosis. Clinicopathological implications. Minerva Ginecol. 2003 ; 55 (4). 333-345
36. Gupta S, Agarwal A, Sekhon L, Krajcir N, Cocuzza M, Falcone T. Serum and peritoneal abnormalities in endometriosis: potential use as diagnostic markers. Minerva Ginecol. 2006 ; 58 (6). 527-551
37. D'Hooghe TM, Bambra CS, Xiao L, Peixe K, Hill JA. Effect of menstruation and intrapelvic injection of endometrium on inflammatory parameters of peritoneal fluid in the baboon (Papio anubis and Papio cynocephalus). Am J Obstet Gynecol. 2001 ; 184 (5). 917-925
38. Fruet AC, Seito LN, Rao VL, Di Stasi LC. Dietary intervention with narrow-leaved cattail rhizome flour (Typha angustifolia L.) prevents intestinal inflammation in the trinitrobenzenesulphonic acid model of rat colitis. BMC Complement Altern Med. 2012 ; 12: 62
39. Qin Q, Niu J, Wang Z, Xu W, Qiao Z, Gu Y. Astragalus embranaceus extract activates immune response in macrophages via heparanase. Molecules. 2012 ; 17 (6). 7232-7240
40. Rahimi R, Shams-Ardekani MR, Abdollahi M. A review of the efficacy of traditional Iranian medicine for inflammatory bowel disease. World J Gastroenterol. 2010 ; 16 (36). 4504-4514
41. Cheng L, Lei Y, Liang YY, Tang DX, Huang L, Tan ZH. Compared studies on the effect and toxicity of extractions of Fructus Meliae Toosendan in mice [in Chinese]. Zhong Yao Cai. 2007 ; 30 (10). 1276-1279
42. Binder BR, Mihaly J. Prager GW. uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view. Thromb Haemost. 2007 ; 97 (3). 336-342
43. Myers CL, Wertheimer SJ, Schembri-King J, Parks T, Wallace RW. Induction of ICAM-1 by TNF-alpha, IL-1 beta, and LPS in human endothelial cells after downregulation of PKC. Am J Physiol. 1992 ; 263 (4 pt 1). C767 - C772
44. Park YG, Kang SK, Kim WJ, Lee YC, Kim CH. Effects of TGF-beta, TNF-alpha, IL-beta and IL-6 alone or in combination, and tyrosine kinase inhibitor on cyclooxygenase expression, prostaglandin E2 production and bone resorption in mouse calvarial bone cells. Int J Biochem Cell Biol. 2004 ; 36 (11). 2270-2280
45. Chakrabarti S, Zee JM, Patel KD. Regulation of matrix metalloproteinase-9 (MMP-9) in TNF-stimulated neutrophils: novel pathways for tertiary granule release. J Leukoc Biol. 2006 ; 79 (1). 214-222
46. Fontana VA, Sanchez M, Cebral E, Calvo JC. Interleukin-1 beta regulates metalloproteinase activity and leptin secretion in a cytotrophoblast model. Biocell. 2010 ; 34 (1). 37-43
47. Nee LE, McMorrow T, Campbell E, Slattery C, Ryan MP. TNF-alpha and IL-1beta-mediated regulation of MMP-9 and TIMP-1 in renal proximal tubular cells. Kidney Int. 2004 ; 66 (4). 1376-1386
48. Guo SW. Nuclear factor-kappab (NF-kappaB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large?. Gynecol Obstet Invest. 2007 ; 63 (2). 71-97
49. Xue J, Thippegowda PB, Hu G, et al. NF-kappaB regulates thrombin-induced ICAM-1 gene expression in cooperation with NFAT by binding to the intronic NF-kappaB site in the ICAM-1 gene. Physiol Genomics. 2009 ; 38 (1). 42-53
50. Jung YJ, Isaacs JS, Lee S, Trepel J, Neckers L. IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J. 2003 ; 17 (14). 2115-2117
51. Chou YC, Sheu JR, Chung CL, et al. Nuclear-targeted inhibition of NF-kappaB on MMP-9 production by N-2-(4-bromophenyl) ethyl caffeamide in human monocytic cells. Chem Biol Interact. 2010 ; 184 (3). 403-412
52. Bommarito A, Richiusa P, Carissimi E, et al. BRAFV600E mutation, TIMP-1 upregulation, and NF-kappaB activation: closing the loop on the papillary thyroid cancer trilogy. Endocr Relat Cancer. 2011 ; 18 (6). 669-685
53. D'Hooghe TM, Kyama CM, Chai D, et al. Nonhuman primate models for translational research in endometriosis. Reprod Sci. 2009 ; 16 (2). 152-161